2026 California Thoracic Society Annual Educational Conference & Chronic Obstructive Pulmonary Disease Symposium

This conference brings together regional and national experts to discuss the latest advances in Pulmonary, Critical Care and Sleep Medicine.

Thursday is dedicated to a multidisciplinary symposium on chronic obstructive pulmonary disease which includes discussion of epidemiology, heterogeneity, novel medications, interventional techniques, and advanced therapies.

Friday will cover the topics of advances in the field of interventional pulmonary, remote monitoring tools to assist in the care of patients with lung disease and sleep disorders, and approaches to symptom management in the patient with lung disease.

Saturday will cover advances in the management of the septic patient, an update on how and when to use extracorporeal membrane oxygenation, and the inpatient and pulmonary complications of cancer care.

Target Audience

The program is designed for Pulmonologists, Critical Care Physicians, Internal Medicine Physicians, Hospitalists, Radiologists, Sleep Specialists, In-Training Fellows and Residents, Nurse Practitioners, Physician Assistants, Registered Nurses, Respiratory Therapists, Sleep Technologists, Pharmacists, and other healthcare professionals in the fields of Pulmonary, Critical Care, and Sleep Medicine.

Learning Objectives

  • Discuss the epidemiology of chronic obstructive pulmonary disease, how to make the diagnosis, and the current pharmacologic approaches to treatment in this population
  • Recognize the proper use of ancillary services in treating the patient with chronic obstructive pulmonary disease including oxygen, non-invasive ventilation, endobronchial valves, pulmonary rehabilitation, and lung transplantation
  • Describe the heterogeneity in presentation of patients with chronic obstructive lung disease and how this impacts ventilation and clinical management
  • Discuss the major updates that have occurred in the field of interventional pulmonary, including advanced bronchoscopy techniques and pleural disease management
  • Recognize the value in remote monitoring for the patient with lung disease and sleep disorders, and how remote monitoring can improve patient care
  • Describe how pulmonary practitioners can manage symptoms of lung disease and how palliative care services should be employed
  • Recognize how the approach to treating sepsis has changed in recent years and how phenotyping patients with sepsis can improve outcomes
  • Discuss the way that extracorporeal membrane oxygenation can assist recovery for patients with respiratory failure and when to refer patients for this therapy
  • Describe how treatment of malignancy can lead to multiple respiratory illnesses as well as critical illness and understand how to manage the patient with an oncologic emergency

Commercial Support
This activity has received in-kind support from Olympus.

Course summary
Available credit: 
  • 19.00 AANP
  • 19.00 AAPA Category 1 CME
  • 19.00 ABIM Medical Knowledge
  • 19.00 AMA PRA Category 1 Credit
  • 19.00 ANCC
  • 19.00 Attendance
Course opens: 
03/12/2026
Course expires: 
01/01/2027
Cost:
$0.00
Rating: 
0

Thursday March 12, 2026

Non-CME Program

10:00 am – 11:00 am: Brunch with presentation - Location: Portola Hotel, The Club Room, Sponsored by: Sanofi & Regeneron

Topic: Choose Dupixent When Triple Inhaled Therapy is Not Enough
Speaker: Tariq Cheema, MD

COPD Medical Management, Pathogenesis, and Epidemiology

CME Program

Location: Monterey Convention Center (Floor 2), Steinbeck 1 & 2

11:00 am - 11:45 am: Keynote Address –The Immunology of Obstructive Lung Disease

Frank Sciurba, MD (University of Pittsburgh) – This speaker will discuss the immunology of COPD and discuss novel approaches to anti-inflammatory medications and biologic therapy in COPD.

11:45 am - 12:10 pm: Diagnosis and Case Finding in COPD

Stephanie Christenson, MD (UC San Francisco) – This speaker will discuss the diagnosis of COPD and new approaches for case finding using screening questionnaires, spirometry, and peak expiratory flow.

12:10 pm - 12:35 pm: Epidemiology of COPD

Laura Myers, MD (Kaiser) – This speaker will discuss the global, US, and California burden of COPD, the regional variability of COPD, and how COPD prevalence varies by social determinants of health.

12:35 pm – 1:00 pm: Update on the treatment algorithm of COPD from the 2025 GOLD Report

Anil Ghimire, MD (UCSF Fresno) – This speaker will discuss the updated 2025 GOLD Report on COPD and how to approach therapy in this population with the current available modalities.
1:00 pm - 1:10 pm - Question and Answer

1:10 - 2:10 pm: Lunch Location: Portola Hotel, The Club Room

Non-Medication Based Management in COPD

2:10 pm – 2:35 pm: Oxygen and Non-Invasive Ventilation in COPD

Solmaz Ehteshami-Afsha, MD (Stanford) – This speaker will discuss the benefits of oxygen supplementation in COPD and the nuances of non-invasive ventilation in patients with COPD.

2:35 pm – 3:00 pm: Endobronchial valves in COPD

Madhav Chopra, MD (University of Arizona–Tucson) – This speaker will discuss when to use endobronchial valves in COPD and the benefits and limitations of endobronchial valves.

3:00 pm – 3:25 pm: Pulmonary Rehabilitation for COPD

Richard Casaburi, MD PhD (Harbor-UCLA) – This speaker will discuss how pulmonary rehabilitation can improve outcomes in patients with COPD, and how virtual pulmonary rehabilitation programs can benefit patients with COPD.

3:25 pm – 3:50 pm: Heterogeneity in COPD from diagnosis to ventilation

Brooks Kuhn, MD (UC Davis) – This speaker will discuss the various phenotypes of COPD and how this impacts ventilation. They will also cover how to measure and treat ventilation heterogeneity in COPD.
3:50 pm – 4:00 pm – Question and Answer

4:00 pm – 4:40 pm: Coffee Break and Refreshments with exhibitors Location: Portola Hotel, De Anza Lobby

In the Weeds of COPD

4:40 pm – 5:05 pm: Genetics in COPD

Russell Buhr, MD PhD (UC Los Angeles) – This speaker will discuss various genetic factors associated with COPD, including Alpha-1 Antitrypsin Deficiency, and how clinical management differs in those with genetic-associated COPD.

5:05 pm – 5:30 pm: Pulmonary Hypertension from COPD

Yuri Matusov, MD (Cedars-Sinai) – This speaker will discuss how patients with COPD can develop Pulmonary Hypertension the management of PH-COPD, and upcoming trials focused on PH-COPD.

5:30 pm – 5:55 pm: Lung Transplant for COPD

Julia Maheshwari, MD (UC San Francisco) – This speaker will discuss the referral criteria for lung transplantation in patients with COPD, and how transplantation can improve quality of life for patients with COPD.

5:55 pm – 6:20 pm: Population Health Approach to COPD

Krystal Craddock, MSRC RRT (UC Davis) - This speaker will discuss how health system approaches can improve care for patients with COPD.
6:20 pm – 6:30 pm – Question and Answer

Non-CME Program

Conference Meet and Greet Welcome Reception and Presentation

7:00 pm – 8:30 pm: Location: Portola Hotel, The Club Room, Sponsored by: GSK
Topic: Are Your Patients at Greater Risk of COPD Exacerbations? It Is Time to Rethink Management for COPD With an Eosinophilic Phenotype
Speaker: Ronald Balkissoon, MD, MSc, DIH, FRCPC

Friday March 13, 2026

Non-CME Program

7:00 am – 7:45 am: Breakfast with presentation - Location: Portola Hotel, Bonsai Ballroom, Sponsored by: AstraZeneca

Topic: Join the Conversation! Topics in Respiratory Care.
Speakers: Lauren Eggert, MD (UCSF)

Advances in Interventional Pulmonary

CME Program

Location: Portola Hotel, De Anza III

8:00 am – 8:10 am: Welcome and Introduction

8:10 am – 8:55 am: Keynote Address – Evolution of Bronchoscopy in Diagnosing Lung Nodules

Christine Argento, MD (Johns Hopkins) - This speaker will discuss the recent advances in bronchoscopy from radial EBUS, to electromagnetic navigation, to robot technologies, and how advancement has improved lung nodule diagnosis.

8:55 am – 9:20 am: Implications of the new TNM9 staging for lung cancer

Colleen Channick, MD (UC Los Angeles) - This speaker will discuss the new TNM staging system, how staging is currently performed, and how to approach staging in the patient with suspected lung cancer.

9:20 am – 9:45 am: Management of Central Airway Obstruction

Raed Alalawi, MD (Arizona-Phoenix) - This speaker will discuss how interventional pulmonary practitioners can manage and treat central airway obstruction.

9:45 am – 10:10 am: The Changing Landscape of Pleural Disease Management

Joon Chang, MD (Stanford) - This speaker will discuss advances in management of pleural disease by the interventional pulmonologist including when to use an intrapleural catheter, and when to use.
10:10 am – 10:20 am: Question and Answer
10:20 am – 10:50 am: Break

Remote Monitoring in Lung Disease and Sleep Medicine

10:50 am – 11:15 am: Developing a home spirometry program

Steven Hays, MD (UC San Francisco) - This speaker will discuss how to approach the development of a home spirometry program to monitor lung disease, how to use digital health technologies to integrate results into the EHR.

11:15 am – 11:40 am: Home Non-Invasive Ventilator Monitoring

Christal Hawkins, RRT (UC San Diego)  - This speaker will review how to monitor home non-invasive ventilators for compliance and for adequate control of sleep disordered breathing.

11:40 am – 11:55 am: Pro: Virtual Pulmonary Rehabilitation is Ready for Prime Time

Aimee Kizziar, RRT (UC Davis) - This speaker will argue in favor of virtual pulmonary rehabilitation programs.

11:55 am – 12:10 pm: Con: Virtual Pulmonary Rehabilitation is not ready for Prime Time

Julia Rigler, BA. RRT (UC San Francisco) - This speaker will argue against virtual pulmonary rehabilitation programs.
12:10 pm – 12:20 pm: Question and Answer

12:20 pm – 1:00 pm: Awards Ceremony

1:00 pm – 2:00 pm: Lunch Location: Portola Hotel, De Anza I & II

Hands On Session:

Location: Portola Hotel, Portola Room

2:00 pm – 3:00 pm:
Robotic Bronchoscopy Raed Alalawi, MD (Arizona-Phoenix) & Joon Chang, MD (Stanford)
Cough Monitoring Lauren Eggert, MD (UCSF)
Endobronchial Ultrasound Pranjal Patel, MD (Stanford)
Home NIV Krystle Leung, MD (Stanford)

3:00 pm – 3:20 pm: Coffee Break and Refreshments with exhibitors: Location: Portola Hotel, De Anza I & II

Approach to Symptom Management in the Pulmonary Patient

3:20 pm – 3:45 pm: Addressing the Unmet Needs of Refractory Chronic Cough

Krishna Sundar, MD FCCP FAASM ATSF (UC Davis) - This speaker will discuss the etiology behind refractory chronic cough and the treatment approaches for management.

3:45 pm – 4:10 pm: Frailty in Pulmonary and Critical Care Medicine

Jonathan Singer, MD MPH (UC San Francisco) - This speaker will discuss the concept of frailty and how it impacts health in patients with lung disease. The speaker will also discuss how frailty can change as lung disease is treated.

4:10 pm – 4:35 pm: Palliative Care for the Patient with Chronic Lung Disease

Grace Amadi, MD (UC Davis) - This speaker will discuss how palliative care teams can benefit patients with chronic various lung disease including ILD, COPD, and pulmonary hypertension.

4:35 pm – 5:00 pm: Palliative Care for the Patient with Critical Illness

B. Corbett Walsh, MD, MBE (UC Los Angeles) - This speaker will discuss how palliative care teams can benefit the inpatient with advancing lung disease, the importance of advance care planning, and palliative care in the intensive care unit.

5:00 pm – 5:10 pm: Question and Answer

Non-CME Program

Women in Pulmonary, Critical Care, and Sleep Medicine

5:30 pm – 7:00 pm: Food and beverages will be served - Location: Bonsai Ballroom
Forum Leaders: Shazia Jamil, MD & Jessica Goggin, PhD, MAS, RN

Saturday March 14, 2026

Non-CME Program

7:00 am – 7:45 am: Breakfast with presentation - Location: Portola Hotel, Bonsai Ballroom, Sponsored by: Boehringer Ingelheim

Topic: JASCAYD ® (nerandomilast) tablets: An Update to the Treatment Landscape
Speakers: Dr. Toby Maher (USC)

Advances in Management of the Patient with Sepsis

CME Program

Location: Portola Hotel, De Anza III

8:00 am – 8:10 am: Welcome and Introduction

8:10 am – 8:55 am: Keynote Address – Phenotyping and Personalized Medicine in Sepsis

Angela Rogers, MD (Stanford) - This speaker will discuss phenotyping in the patient with sepsis and septic shock and how close we are to precision medicine in managing sepsis.

8:55 am – 9:20 am: Incorporating Artificial Intelligence Decision Making in Identifying Sepsis

Gabriel Wardi, MD (UC San Diego) - This speaker will describe how artificial intelligence can be used to identify the septic patient before they present with end stage symptoms to impact care earlier in the course of illness.

9:20 pm – 9:35 pm: Pro: The Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) Bundle Saves Lives

Sean Townsend, MD (CPMC-Sutter) - This speaker will argue the benefits of the SEP-1 Bundle/how it saves lives.

9:35 pm – 9:50 pm: Con: The Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) Bundle Does Not Save Lives

Natalie Achamallah, MD, MS (Cottage Health) - This speaker will argue the against the SEP-1 Bundle/highlight its limitations.

9:50-10:00 am Question and Answer
10:00 am – 10:30 am: Break - Coffee and Refreshments with exhibitors - Location: De Anza Lobby

Extracorporeal Membrane Oxygenation

10:30 am – 10:55 am: When to refer to an ECMO center and when to deploy ECMO

Nida Qadir, MD (UC Los Angeles) - This speaker will discuss the evidence behind the use of ECMO in patients with respiratory failure and when providers should consider referral to an ECMO center and when centers should use ECMO.

10:55 am – 11:20 am: What about ECMO to go?

Mazen Odish, MD (UC San Diego) - This speaker will discuss the advent of mobile ECMO services, how they can help improve patient care, and the use of extracorporeal cardiopulmonary resuscitation.

11:20 am – 11:45 pm: Ventilator Strategies for the patient on ECMO

Abirami Kumaresan, MD (Cedars-Sinai) - This speaker will discuss how ventilator strategies may differ in the patient on ECMO and how different ECMO configurations impact which ventilator strategy to use.

11:45 pm – 12:10 pm: What you need to know about pediatric ECMO

Kathleen Ryan, MD (Stanford) - This speaker will discuss the utility of ECMO in neonates and children, and the complexities of management in children who needs mechanical support.
12:10 pm – 12:20 pm: Question and Answer
12:20 pm – 1:20 pm: Lunch Location: Portola Hotel, De Anza I & II

Hands-On Session:

Location: Portola Hotel, Portola Room

1:20 pm – 2:20 pm:
Non-Invasive Cardiac Output Monitors Abirami Kumaresan, MD (Cedars-Sinai)
ECMO Machines Mazen Odish, MD (UC San Diego)
ECMO Placement David Gordon, DNP (UC San Francisco)
Ventilator Settings and Portable ventilators Joe Van Vleet, RT (UC Los Angeles) & Theresa Cantu, RT (Valley Children’s)

2:20 pm – 2:45 pm: Coffee Break and Refreshments with exhibitors - Location: De Anza Lobby

Inpatient and Pulmonary Complications of Cancer Care

2:45 pm – 3:10 pm: Pulmonary Complications of Hematopoietic Stem Cell Transplantation

Husham Sharifi, MD (Stanford) - This speaker will discuss the pulmonary complications that arise after HCT, in particular the development of bronchiolitis obliterans syndrome and approaches to management.

3:10 pm – 3:35 pm: Pulmonary Vascular Complications of Malignancy

Naomi Habib, MD (Norton Thoracic Institute) -  This speaker will discuss the Pulmonary Vascular Disease complications of malignancy including PA sarcoma, pulmonary tumor thrombotic microangiopathy, and medications that can cause PAH.

3:35 pm – 4:00 pm: Drug induced Interstitial Lung Disease and Pneumonitis During Cancer Therapy

Weijia Chua, MD (Stanford) -  This speaker will discuss the pulmonary complications of interstitial lung disease and pneumonitis that develop after chemotherapy and targeted immunotherapy

4:00 pm – 4:25 pm: Respiratory Complications of Acute Leukemia

Hugh Davis, MD (City of Hope) - The speaker will discuss various oncologic emergencies, how they are recognized, and how they are managed in the acute setting.

4:25 pm – 4:35 pm: Question and Answer

Non-CME Program

Trainee Poster Competition

5:30 pm – 7:30 pm: Location: Portola Hotel, De Anza I & II, Sponsored by: Verona Pharma – Food and beverages will be served

 

Sunday March 15, 2026 (Non-CME)

8:00 am – 9:00 am: Board and Faculty Breakfast with Presentation - Location: Portola Hotel, The Portola Room, Sponsored by: Insmed

Topic: BRINSUPRI: The First and Only FDA-Approved Treatment Specifically for Bronchiectasis
Speakers: Richard Belkin, MD

Resident/Fellows Track Symposium

Location: Portola Hotel, Bonsai Room

Pathways for Emerging Leaders

9:00 am – 9:20 am Map the Leadership Landscape: Clinical perspective.

Lekshmi Santhosh, MD (UCSF) The speaker will focus on ways trainees can develop as leaders during training by leading a clinical team, demonstrating leadership aptitude as chief residents/fellow or through other clinical opportunities.

9:20 am – 9:40 am Leadership opportunities as a clinical educator

Tisha Wang, MD (UCLA) The speaker will discuss ways to identify one’s default leadership style, how residents/fellows can find leadership opportunities in the clinical educator pathway, and how to get connected to professional societies.

9:40-10:00 am Question and Answer

Resilience and Practical Habits for Sustainable Clinicians

10:00 am – 10:15 am: Shift Work and Sleep

Shazia Jamil, MD (Scripps) This speaker will discuss the science behind shifting sleep schedules and ways to help

adjustments during rotations.

10:15 am – 10:30 am: How to navigate personal/family life “blend” with work life

Lauren Eggert, MD (UCSF) This speaker will discuss tips to developing strategies during training that will continue to serve

you throughout your career.

10:30 am – 10:45 am: Saying “No” Without Burning Bridges

Brooks Kuhn, MD (UC Davis) This speaker will discuss how one can make the most of their non-clinical time to serve career

aspirations, when and how to say no

10:45-11:00 am Question and Answer

11:00 am – 12:15 pm: Problem-Based Learning (NON-CME)

Sponsored by: Sanofi & Regeneron

Topic: PBL COPD Case Participant Guide: A 57-Year-Old Female with COPD Experiencing Worsening Symptoms
Speakers: Reymond Panettieri, MD

12:15 pm – 12:30 pm: Wrap-Up

March 12-15, 2026 in Monterey, CA
United States

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product 
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer 
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

Committee Member, Planner, Staff(s)

Raed Alalawi, MD, FCCP

has no relevant financial relationships to disclose at this time.

Theresa Cantu, MSRC, RRT-NPS, AE-C

has a financial relationship (Consultant) with Aerogen;.

Diana Chen

has no relevant financial relationships to disclose at this time.

Lauren Eggert, MD

has a financial relationship (Advisor) with GSK;.
has a financial relationship (Advisor) with Genentech;.
has a financial relationship (Consultant) with Nestwell;.
has a financial relationship (Advisor) with AstraZeneca;.
has a financial relationship (Speaker) with GSK;.
has a financial relationship (Advisor) with Regeneron/Sanofi;.

Laura Glassman

has a financial relationship (Consultant) with Intuitive Surgical;.

Nicholas Kolaitis, MD MAS

has a financial relationship (Consultant) with Johnson and Johnson;.
has a financial relationship (Consultant) with Gossamer;.
has a financial relationship (Consultant) with Merck;.
has a financial relationship (Consultant) with United Therapeutics;.

Laura Myers, MD MPH

has no relevant financial relationships to disclose at this time.

Nida Qadir, MD

has no relevant financial relationships to disclose at this time.

Joseph Van Vleet, BSRC, RRT, RCP

has no relevant financial relationships to disclose at this time.

Janine Vintch, Clinical Professor of Medicine, David Geffen School of Medicine at UCLA; Harbor-UCLA Medical Center; Director Sleep Center Services and Pulmonary Embolism Response Team

has no relevant financial relationships to disclose at this time.
Speaker, Instructor, Faculty(s)

Natalie Achamallah

has a financial relationship (Researcher) with Translational Sciences;.

Raed Alalawi, MD, FCCP

has no relevant financial relationships to disclose at this time.

Grace Amadi, MD

has no relevant financial relationships to disclose at this time.

Angela Argento, MD

has a financial relationship (Consultant) with Cook Medical;.
has a financial relationship (Consultant) with BD;.
has a financial relationship (Advisor) with AstraZeneca;.
has a financial relationship (Advisor) with Daiichi Sankyo;.
has a financial relationship (Consultant) with ERBE;.
has a financial relationship (Independent contractor (including contracted research)) with Olympus;.

Russell Buhr, MD, PhD, FACP, ATSF

has a financial relationship (Consultant) with Chiesi;.
has a financial relationship (Consultant) with Optum;.

Theresa Cantu, MSRC, RRT-NPS, AE-C

has a financial relationship (Consultant) with Aerogen;.

Richard Casaburi, Distinguished Professor of Medicine

has no relevant financial relationships to disclose at this time.

Joon Chang, MD

has no relevant financial relationships to disclose at this time.

Colleen Channick, MD

has a financial relationship (Consultant) with Intuitive Surgical;.

Diana Chen

has no relevant financial relationships to disclose at this time.

Madhav Chopra, MD

has no relevant financial relationships to disclose at this time.

Stephanie Christenson, MD MAS

has a financial relationship (Researcher) with Uniquity Bio;.
has a financial relationship (Advisor) with Sanofi;.
has a financial relationship (Speaker) with Sanofi;.
has a financial relationship (Advisor) with Regeneron;.
has a financial relationship (Speaker) with Regeneron;.
has a financial relationship (Advisor) with AstraZeneca;.
has a financial relationship (Speaker) with AstraZeneca;.
has a financial relationship (Advisor) with Abbvie;.
has a financial relationship (Advisor) with Apogee Therapeutics;.
has a financial relationship (Advisor) with Genentech;.
has a financial relationship (Advisor) with GlaxoSmithKline;.
has a financial relationship (Advisor) with Verona Pharma;.
has a financial relationship (Advisor) with Amgen;.
has a financial relationship (Advisor) with Devpro Biopharma/Uniquity Bio;.
has a financial relationship (Advisor) with Kymera Therapeutics;.
has a financial relationship (Advisor) with Gilead;.

Weijia Chua

has no relevant financial relationships to disclose at this time.

Krystal Craddock, MSc, RRT, RRT-NPS, AE-C, RRT-ACCS, FAARC

has a financial relationship (Speaker) with Theravance Biopharma;.
has a financial relationship (Speaker) with Electromed;.
has a financial relationship (Speaker) with Sentec;.
has a financial relationship (Researcher) with Fisher & Paykel;.

Hugh Davis, MD

has no relevant financial relationships to disclose at this time.

Lauren Eggert, MD

has a financial relationship (Advisor) with GSK;.
has a financial relationship (Advisor) with Genentech;.
has a financial relationship (Consultant) with Nestwell;.
has a financial relationship (Advisor) with AstraZeneca;.
has a financial relationship (Speaker) with GSK;.
has a financial relationship (Advisor) with Regeneron/Sanofi;.

Solmaz Ehteshami Afshar, MD, MSc

has no relevant financial relationships to disclose at this time.

Anil Ghimire

has no relevant financial relationships to disclose at this time.

Laura Glassman

has a financial relationship (Consultant) with Intuitive Surgical;.

David Gordon, DNP

has no relevant financial relationships to disclose at this time.

Naomi Habib, MD

has a financial relationship (Consultant) with United therapeutics;.
has a financial relationship (Consultant) with Merck;.
has a financial relationship (Consultant) with Liquidia;.
has a financial relationship (Consultant) with Johnson & Johnson;.

Christal Hawkins, BSRT, RRT

has no relevant financial relationships to disclose at this time.

Steven Hays

has a financial relationship (Consultant) with CareDx;.

Aimee Kizziar, MHAL, RCP, RRT-NPS, AE-C, CES, FAACVPR

has no relevant financial relationships to disclose at this time.

Nicholas Kolaitis, MD MAS

has a financial relationship (Consultant) with Johnson and Johnson;.
has a financial relationship (Consultant) with Gossamer;.
has a financial relationship (Consultant) with Merck;.
has a financial relationship (Consultant) with United Therapeutics;.

Brooks Kuhn, MD, MAS

has a financial relationship (Consultant) with Sanofi;.
has a financial relationship (Consultant) with Regeneron;.
has a financial relationship (Consultant) with Verona;.
has a financial relationship (Consultant) with GSK;.

Abirami Kumaresan, MD

has no relevant financial relationships to disclose at this time.

Krystle Leung

has no relevant financial relationships to disclose at this time.

Julia Maheshwari, MD

has no relevant financial relationships to disclose at this time.

Yuri Matusov, MD, FACP, ATSF

has a financial relationship (Researcher) with Penumbra;.
has a financial relationship (Researcher) with Mallinckrodt;.
has a financial relationship (Researcher) with Tenax;.
has a financial relationship (Consultant) with Jupiter Endovascular;.

Laura Myers, MD MPH

has no relevant financial relationships to disclose at this time.

Mazen Odish, M.D.

has no relevant financial relationships to disclose at this time.

PRANJAL PATEL, MD, DAABIP

has a financial relationship (Consultant) with Johnson and Johnson;.

Nida Qadir, MD

has no relevant financial relationships to disclose at this time.
has no relevant financial relationships to disclose at this time.

julia rigler, RCP

has a financial relationship (Consultant) with Kivo Health;.

Angela Rogers

has no relevant financial relationships to disclose at this time.

Kathleen Ryan

has no relevant financial relationships to disclose at this time.

Frank Sciurba, M.D., FCCP

has a financial relationship (Consultant) with Sanofi/Regeneron;.
has a financial relationship (Consultant) with AstraZeneca;.
has a financial relationship (Consultant) with GlaxoSmithKline;.
has a financial relationship (Consultant) with Genentech;.
has a financial relationship (Researcher) with Sanofi/Regeneron;.
has a financial relationship (Researcher) with AstraZeneca;.
has a financial relationship (Researcher) with Verona Pharma;.
has a financial relationship (Researcher) with Nuvaira;.
has a financial relationship (Researcher) with Gala Therapeutics;.
has a financial relationship (Researcher) with Pulmonx;.

Husham Sharifi, MD, MS

has no relevant financial relationships to disclose at this time.

Jonathan Singer, MD MS

has a financial relationship (Consultant) with XVIVO;.
has a financial relationship (Consultant) with Krystal Biotechnology;.
has a financial relationship (Consultant) with Mallinckrodt Pharmaceuticals;.

Krishna Sundar

has a financial relationship (Advisor) with GSK Pharma;.
has a financial relationship (Advisor) with Trevi Therapeutics;.
has a financial relationship (Independent contractor (including contracted research)) with Phillips Respironics;.

Sean Townsend, M.D.

has no relevant financial relationships to disclose at this time.

Joseph Van Vleet, BSRC, RRT, RCP

has no relevant financial relationships to disclose at this time.

Janine Vintch, Clinical Professor of Medicine, David Geffen School of Medicine at UCLA; Harbor-UCLA Medical Center; Director Sleep Center Services and Pulmonary Embolism Response Team

has no relevant financial relationships to disclose at this time.

b. corbett walsh, MD, MBE

has no relevant financial relationships to disclose at this time.

Gabriel Wardi, MD, MPH

has no relevant financial relationships to disclose at this time.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and and California Thoracic Society (CTS). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

 

This activity was planned by and for the healthcare team, and learners will receive 19.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

 

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 19.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 19.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 19.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

 

Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and California Thoracic Society (CTS).  AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 19.0 contact hour(s) (which includes 19.0 hour(s) of pharmacology).

 

Continuing Education for Nurses, Respiratory Therapists, Respiratory Care Practitioners, and Other Associates

The California Thoracic Society is approved by the California Board of Registered Nursing, Provider #CEP599 for a total of 19 contact hours.  Note: 6 CEU credits are available for Thursday; 6.5 CEU credits are available for Friday; 6.5 CEU credits are available for Saturday.  The course meets the requirements for CE for RCPs in California.

Attendees should only claim credits commensurate with the extent of their participation in the activity.

 

Available Credit

  • 19.00 AANP
  • 19.00 AAPA Category 1 CME
  • 19.00 ABIM Medical Knowledge
  • 19.00 AMA PRA Category 1 Credit
  • 19.00 ANCC
  • 19.00 Attendance

Price

Cost:
$0.00
Please login or register to take this course.